Pfizer Inc. (PFE)
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock has likely bottomed and shows strong technical and fundamental indicators, including a "Golden Cross" and robust cost reduction plans. The company's promising pipeline, including weight-loss treatments and AI-driven drug discovery, offers significant long-term upside potential. The Seagen acquisition enhances Pfizer's cancer treatment portfolio, positioning it well in a high-demand sector.
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Starboard Value has taken a $1 billion stake in drugmaker Pfizer. The hedge fund, headed by Jeff Smith, has become one of the most feared activist investors.
Pfizer needs to 'fix what they have', no M&A capacity, says BMO's Evan Seigerman on activist stake
Evan David Seigerman, BMO Biotech Analyst, joins 'Closing Bell Overtime' to talk Pfizer shares climbing on activist firm Starboard taking a stake in the company.
Chart of the Day: Pfizer
Starboard takes a $1 billion stake in $PFE. It's our Chart Of The Day.
Starboard Value takes up $1 billion stake in Pfizer: WSJ
Pharmaceutical giant Pfizer (PFE) is seeing stock gains in Monday's pre-market trading after activist investor Starboard Value took up a $1 billion stake, according to a Wall Street Journal report. Yahoo Finance senior health reporter Anjalee Khemlani covers Starboard's reported investment in Pfizer as the pharma company seeks to reposition itself coming out of the COVID-19 pandemic.
Pfizer (PFE) Surges on Starboard's $1 Billion Investment Plan
Pfizer (PFE, Financial) stock saw a notable increase of 2.94% attributed to a reported $1 billion investment by activist investor Starboard Value. This strategic move is intended to breathe new life into Pfizer, as the stock has experienced a substantial decrease from its highs during the pandemic era.
Why Pfizer Stock Popped on Monday
Can Starboard Value and former CEO Ian Read save Pfizer stock?
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
Pfizer stock popped Monday on a report activist investor Starboard Value took a roughly $1 billion stake in the struggling drugmaker.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Starboard Value's $1 Billion Stake Boosts Pfizer (PFE) Shares
Media reports indicate that activist investor Starboard Value has acquired approximately $1 billion worth of shares in Pfizer (PFE, Financial). Following this news, Pfizer's stock rose nearly 3% in pre-market trading.
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Pfizer Inc. NYSE: PFE hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE NASDAQ: BNTX sent shares surging up to $61.71 in December 2021, driven by its COVID-19 vaccine sales. Since then, it's been downhill for the medical sector giant as COVID revenues dried up with the pandemic in the rearview mirror.
